Evidence map›Paper›PMID 26447946›Full record

ArticlePloS one2015

GATA1 and PU.1 Bind to Ribosomal Protein Genes in Erythroid Cells: Implications for Ribosomopathies.

Elsa P Amanatiadou, Giorgio L Papadopoulos, John Strouboulis, Ioannis S Vizirianakis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Myeloid and erythroid hematopoietic transcription factor expression decline after knockdown ofZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2016
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Elsa P AmanatiadouLaboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Giorgio L PapadopoulosDivision of Molecular Oncology, Biomedical Sciences Research Center "Alexander Fleming", Vari, Greece.
John StrouboulisDivision of Molecular Oncology, Biomedical Sciences Research Center "Alexander Fleming", Vari, Greece.
Ioannis S VizirianakisLaboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRAlexander Fleming Biomedical Sciences Research Center · GRMolecular Oncology (United States) · US

Funding

Functional proteomics in differentiating erythroid cellsR01DK083389 · NIDDK · UNIVERSITY OF FLORIDA · PI BUNGERT, JORG, STROUBOULIS, IOANNIS JOHN · 2010 to 2013
$1.1M
NIDDK NIH HHS R01 DK083389NIDDK NIH HHS R01DK083389
6 · The paper itself

Abstract

The clear connection between ribosome biogenesis dysfunction and specific hematopoiesis-related disorders prompted us to examine the role of critical lineage-specific transcription factors in the transcriptional regulation of ribosomal protein (RP) genes during terminal erythroid differentiation. By applying EMSA and ChIP methodologies in mouse erythroleukemia cells we show that GATA1 and PU.1 bind in vitro and in vivo the proximal promoter region of the RPS19 gene which is frequently mutated in Diamond-Blackfan Anemia. Moreover, ChIPseq data analysis also demonstrates that several RP genes are enriched as potential GATA1 and PU.1 gene targets in mouse and human erythroid cells, with GATA1 binding showing an association with higher ribosomal protein gene expression levels during terminal erythroid differentiation in human and mouse. Our results suggest that RP gene expression and hence balanced ribosome biosynthesis may be specifically and selectively regulated by lineage specific transcription factors during hematopoiesis, a finding which may be clinically relevant to ribosomopathies.

Indexed as

AnimalsCell DifferentiationCell Line, TumorErythroid CellsGATA1 Transcription FactorGene Expression RegulationHematopoiesisMicePromoter Regions, GeneticProtein BindingProteostasis DeficienciesProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Ribosomal ProteinsTrans-ActivatorsGata1 protein, mouseGATA1 Transcription FactorProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Ribosomal ProteinsRps19 protein, mouseTrans-Activators

Identifiers

PMID26447946
PMCPMC4598024
OpenAlexW2290443773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.